Stockreport

Nykode Therapeutics AS (VACBF) Q4 2025 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF This article first appeared on GuruFocus Revenue: No revenue in Q4 2025 compared to $6.8 million in Q4 2024. Operating Expenses: Reduced from $12.9 million in Q4 20 [Read more]